**ÀϽÃ: 2014.5.17 (Åä)
**Àå¼Ò: ½ºÀ§Æ®È£ÅÚ ³²¿ø
Grand Ballroom 1 | Grand Ballroom 2 | Suites Hall | Suites Forum 1,3 |
|
08:20~08:50 | Registration | Poster Exhibition |
||
08:50~09:00 | Opening | |||
09:00~09:50 | Session I: ¿¬±¸ºñ ¹× ÀåÇÐ±Ý ¹ßÇ¥ | |||
09:50~10:40 | Session II: Á¤Ã¥°úÁ¦ °á°ú º¸°í | |||
10:40~11:00 | Coffee break | |||
11:00~12:00 | Session III: Frontier in transplantation | |||
12:00~12:40 | Session IV: Infection after transplantation | |||
12:40~12:50 | ÀÓ½ÃÃÑȸ | |||
12:50~13:10 | Break | |||
13:10~14:00 |
Luncheon Symposium I (¾Æ½ºÅÚ¶ó½º) |
Luncheon Symposium III (»ç³ëÇÇ) |
Luncheon Symposium II (Á¾±Ù´ç) |
|
14:00~15:20 |
Concurrent Symposium I-1 (Management of antibody -mediated rejection |
Concurrent Symposium I-3 (Hot issues in thoracic transplantation) |
Concurrent Symposium I-2 (Viral hepatitis in liver transplantation) |
|
15:20~15:40 | Coffee break | |||
15:40~17:00 |
Concurrent Symposium II-1 (Immunosuppression in kidney transplantation) |
Concurrent Symposium II-3 (Joint session with KOTCO) |
Concurrent Symposium II-2 (Interpretation of liver biopsy in liver transplantation) |
|
17:00~ | Closing |
³»¿ë | ÁÂÀå/¿¬ÀÚ | |
08:20~08:50 | Registration | |
08:50~09:00 | Opening | ÇÑ´öÁ¾(¿ï»êÀÇ´ë, ´ëÇÑÀ̽ÄÇÐȸ ȸÀå) |
09:00~09:50 | Session I: ¿¬±¸ºñ ¹× ÀåÇÐ±Ý ¹ßÇ¥ |
ÁÂÀå: Çã ±æ(ºÀ»ýº´¿ø) ¼°æ¼®(¼¿ïÀÇ´ë) |
09:00~09:15 | À̽ĽŠ°èȹ»ý°Ë ¹× Àç»ý°Ë¿¡¼ kidney injury molecule-1 ÀÇ Ç¥Çö | Á¤ÇöÁÖ(¿¬¼¼ÀÇ´ë) |
09:15~09:30 | ¼±Ãµ¼º ´ãµµ Æó¼âÁõ ȯ¾Æ¿¡¼ ¸»ÃÊÇ÷¾×¿¡ Á¸ÀçÇÏ´Â ¸ðÀÚ°£ microchimerism¿¡ °üÇÑ ¿¬±¸ |
À̳²ÁØ(¼¿ïÀÇ´ë) |
09:30~09:45 | Recurrence of Hepatocellular Carcinoma - Importance of mRECIST Response to Chemoembolization and Tumor Size after LT and Mayo clinic Protocol Review | ±èµÎÁø(ÇѸ²ÀÇ´ë) |
09:50~10:40 | Session II: Á¤Ã¥°úÁ¦ °á°ú º¸°í | ÁÂÀå: À̼®±¸(¼º±Õ°üÀÇ´ë) Á¤»ó¿µ(Àü³²ÀÇ´ë) |
09:50~10:05 | Second report from the Korean Organ Transplantation Registry (KOTRY) | ¾È±Ô¸®(¼¿ïÀÇ´ë) |
10:05~10:15 | ÀÌ½Ä ±â¼ú R&D »ç¾÷ ±âȹ º¸°í | ±è¼ºÁÖ(¼º±Õ°üÀÇ´ë) |
10:15~10:30 | ´ëÇÑÀ̽ÄÇÐȸ Á¤Ã¥°úÁ¦ ÃÖÁ¾º¸°í; Çѱ¹Çü MELD System °³¹ß; °£ÀÌ½Ä ´ë±âÀÚÀÇ »ýÁ¸ºÐ¼® |
±è¸í¼ö(¿¬¼¼ÀÇ´ë) |
10:30~10:40 | KODA ÁøÇຸ°í | ÇÏÁ¾¿ø(¼¿ïÀÇ´ë) |
10:40~11:00 | Coffee Break | |
11:00~12:00 | Session III: Frontier in transplantation | ÁÂÀå: ±èµ¿±¸(°¡Å縯ÀÇ´ë) ±èÀ¯¼±(¿¬¼¼ÀÇ´ë) |
11:00~11:20 | Simultaneous bone marrow and kidney transplantation | ¹ÚÀç¹ü(¼º±Õ°üÀÇ´ë) |
11:20~11:40 | º¹ºÎ ´ÙÀå±â ÀÌ½Ä | ±è´ë¿¬(¿ï»êÀÇ´ë) |
11:40~12:00 | Ç÷°ü¼º º¹ÇÕ Á¶Á÷ À̽ļú | ¿ì»óÇö(´õºíÀ¯º´¿ø) |
12:00~12:40 | Session IV: Infection after transplantation | ÁÂÀå: ¹®Àμº(°¡Å縯ÀÇ´ë) ±è¼ºÁÖ(¼º±Õ°üÀÇ´ë) |
12:00~12:20 | Update on vaccination for transplant candidates and recipients | ±è»óÀÏ(°¡Å縯ÀÇ´ë) |
12:20~12:40 | Infection prevention in solid organ transplant recipients | ¹é°æ¶õ(¼º±Õ°üÀÇ´ë) |
12:40~12:50 | ÀÓ½ÃÃÑȸ | |
12:50~13:10 | Break | |
13:10~14:00 | Luncheon Symposium(¾Æ½ºÅÚ¶ó½º/Á¾±Ù´ç/»ç³ëÇÇ) | |
14:00~15:20 | Concurrent Symposium I-1: Management of antibody-mediated rejection | ÁÂÀå: Á¶È«·¡(¿ï»ê´ëº´¿ø) ¾çö¿ì(°¡Å縯ÀÇ´ë) |
14:00~14:20 | Banff 2013 Meeting Report: Related to Antibody-Mediated Rejection | ±è¿ëÁø(¿µ³²ÀÇ´ë) |
14:20- 14:40 | Clinical Impact of Microcirculation Inflammation in Renal Allograft Tissue | Çã±ÔÇÏ(¿¬¼¼ÀÇ´ë) |
14:40~15:00 | Impact of Non-HLA Antibodies on Antibody-Mediated Rejection | ÀÌ ½Ä(ÀüºÏÀÇ´ë) |
15:00~15:20 | What's new in the treatment of chronic antibody mediated rejection? | Á¤º´ÇÏ(°¡Å縯ÀÇ´ë) |
14:00~15:20 | Concurrent Symposium I-2: Viral hepatitis in liver transplantation | ÁÂÀå: ±è¼øÀÏ(¿¬¼¼ÀÇ´ë) Á¶Àç¿ø(¼º±Õ°üÀÇ´ë) |
14:00~14:26 | New horizon of HCV management | ±èµµ¿µ(¿¬¼¼ÀÇ´ë) |
14:26~14:52 | Emerging role of nucleos(t)ide in post-LT management of HBV | À̱¤¿õ(¼¿ïÀÇ´ë) |
14:52~15:18 | °£ÀÌ½Ä ÈÄ ¹ß»ýÇϴ Ȳ´ÞÀÇ ÀÓ»ó°æ°ú¿Í Ä¡·á | ÃÖÁ¾¿µ(°¡Å縯ÀÇ´ë) |
14:00~15:20 | Concurrent Symposium I-3 : Hot issues in thoracic transplantation | ÁÂÀå: ¹éȿä(¿¬¼¼ÀÇ´ë) ±èÀçÁß(¿ï»êÀÇ´ë) |
14:00~14:26 | Diagnosis and Treatment of Antibody Mediated Rejection After Heart Transplantation | ±èÀçÁß(¿ï»êÀÇ´ë) |
14:26~14:52 | Role of mTOR inhibitor in heart transplantation | ÀÌÇØ¿µ(¼¿ïÀÇ´ë) |
14:52~15:18 | Evaluation of infections in the lung transplant patients | ¹Ú¹«¼®(¿¬¼¼ÀÇ´ë) |
15:20~15:40 | Coffee Break | |
15:40~17:00 | Concurrent Symposium II-1: Immunosuppression in kidney transplantation | ÁÂÀå: ¹Ú¼ö±æ(¿ï»êÀÇ´ë) ±Ç¿ÀÁ¤(ÇѾçÀÇ´ë) |
15:40~16:00 | Current status of steroid/CNI withdrawal | Çã¿ì¼º(¼º±Õ°üÀÇ´ë) |
16:00~16:20 | Immunosuppression in pregnancy and lactation | ±èÁöÀÏ(°¡Å縯ÀÇ´ë) |
16:20~16:40 | Immunosuppression in pediatric patients | ¹Î»óÀÏ(¼¿ïÀÇ´ë) |
16:40~17:00 | New immunosuppressants in pipeline | ¼ºÀº¿µ(ºÎ»êÀÇ´ë) |
15:40~17:00 | Concurrent Symposium II-2: Interpretation of liver biopsy in liver transplantation | ÁÂÀå: °±¸Á¤(°è¸íÀÇ´ë) À¯Èñö(ÀüºÏÀÇ´ë) |
15:40~16:06 | Histological diagnosis of acute cellular rejection in liver transplantation | Á¤Àº¼±(°¡Å縯ÀÇ´ë) |
16:06~16:32 | Differential diagnosis of HCV recurrence and rejection | ÀÌ°æºÐ(¼¿ïÀÇ´ë) |
16:32~16:58 | Various histologic findings of late allograft dysfunction after liver transplantation | ±èÇý·É(¼¿ïÀÇ´ë) |
15:40~17:00 | Concurrent Symposium II-3: Joint session with KOTCO | ÁÂÀå: Á¶¿øÇö(°è¸íÀÇ´ë) ±èº¹³à(»ï¼º¼¿ïº´¿ø) |
15:40~16:00 | Current problems and solutions for deceased donor organ donation in the real field | Àü°æ¿Á(¼¼ºê¶õ½ºº´¿ø) |
16:00~16:30 | Donor derived disease transmission in transplantation | ÇÏ¿µÀº(¼º±Õ°üÀÇ´ë) |
16:30~17:00 | Immunologic tests for organ transplantation | ¹Ú¸íÈñ(Çѱ¹Àå±â±âÁõ¿ø) |
17:00~ | Closing |